These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37201684)

  • 21. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurodevelopmental outcomes after neonatal caffeine therapy.
    Synnes A; Grunau RE
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101160. PubMed ID: 33121916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
    Rostas SE; McPherson C
    Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
    Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine not associated with irritable behaviour in very low-birth-weight infants.
    Maeda T; Sekiguchi K; Wasada R; Ihara K
    Early Hum Dev; 2019 Oct; 137():104835. PubMed ID: 31473373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.
    Mürner-Lavanchy IM; Doyle LW; Schmidt B; Roberts RS; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W; Anderson PJ;
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29643070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hemodynamic effects of caffeine administration in premature infants.
    Soloveychik V; Bin-Nun A; Ionchev A; Sriram S; Meadow W
    J Perinatol; 2009 Mar; 29(3):205-8. PubMed ID: 19052555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of caffeine in infants unresponsive to theophylline in apnea of prematurity.
    Davis JM; Spitzer AR; Stefano JL; Bhutani V; Fox WW
    Pediatr Pulmonol; 1987; 3(2):90-3. PubMed ID: 3588062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of caffeine for apnea of prematurity.
    Dukhovny D; Lorch SA; Schmidt B; Doyle LW; Kok JH; Roberts RS; Kamholz KL; Wang N; Mao W; Zupancic JA;
    Pediatrics; 2011 Jan; 127(1):e146-55. PubMed ID: 21173002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa.
    Ekhaguere OA; Ayede AI; Ezeaka CV
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101182. PubMed ID: 33272903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine for the Treatment of Central Apnea in Trisomy 18: A Case Study in the Novel Use of Methylxanthines in Palliative Transport.
    Ariagno S; Thorvilson M; Andersen L; Collura C
    J Palliat Med; 2022 May; 25(5):840-843. PubMed ID: 34756099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity.
    García-Robles A; Solaz-García Á; Verdú-Andrés J; Andrés JLP; Cañada-Martínez AJ; Pericás CC; Ponce-Rodriguez HD; Vento M; González PS
    Eur J Pediatr; 2022 Dec; 181(12):4175-4182. PubMed ID: 36169712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
    Ducrocq S; Biran-Mucignat V; Boelle PY; Lebas F; Baudon JJ; Gold F
    Arch Pediatr; 2006 Oct; 13(10):1299-304. PubMed ID: 16919922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theophylline or caffeine: which is best for apnea of prematurity?
    Gannon BA
    Neonatal Netw; 2000 Dec; 19(8):33-6. PubMed ID: 11949272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Former preterm infants, caffeine was good for you, but now beware of snoring!
    Poets CF; Khan SR
    Am J Respir Crit Care Med; 2014 Oct; 190(7):720-1. PubMed ID: 25271743
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent research on gene polymorphisms related to caffeine therapy in preterm infants with apnea of prematurity].
    Xie JB; Lin XZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):832-837. PubMed ID: 35894202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
    Dobson NR; Hunt CE
    Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Caffeine in Noninvasive Respiratory Support.
    Dobson NR; Patel RM
    Clin Perinatol; 2016 Dec; 43(4):773-782. PubMed ID: 27837758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.